Evidence map›Paper›PMID 34660846›Full record

ArticleInternational journal of biochemistry and biophysics2021

Signature of Glycylglutamic Acid Structure.

Amanda Hoff, Nigam Rath, John Lisko, Matthias Zeller, Ganesaratnam K Balendiran

Open access · diamondAbstract read
In one paragraph

Article in International journal of biochemistry and biophysics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Molecular dynamics of fibric acids.European journal of chemistry (Print) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Amanda HoffDepartment of Chemistry, Youngstown State University, Youngstown, OH 44555, USA.
Nigam RathDepartment of Chemistry and Biochemistry and Center for Nanoscience, University of Missouri, St. Louis, MO 63121, USA.
John LiskoDepartment of Chemistry, Youngstown State University, Youngstown, OH 44555, USA.
Matthias ZellerDepartment of Chemistry, Youngstown State University, Youngstown, OH 44555, USA.
Ganesaratnam K BalendiranDepartment of Chemistry, Youngstown State University, Youngstown, OH 44555, USA.
Youngstown State University · USCentral DuPage Hospital · USPurdue University West Lafayette · USUniversity of Missouri–St. Louis · US

Funding

Role of fibrate mechanism in diabetes and its complicationsR15DK085496 · NIDDK · YOUNGSTOWN STATE UNIVERSITY · PI BALENDIRAN, GANESARATNAM · 2010 to 2017
$491k
NIDDK NIH HHS R15 DK085496
6 · The paper itself

Abstract

backgroundGlutamate (Glu) is of great interest in biomedical research. It is considered a biomarker in diabetes, which may potentially contribute to the development of autism in genetically vulnerable human populations, and it is found in relation to advanced glycation end products (AGEs) [1]. Additionally, Glu plays an active role in the function of ligand-gated ion channel glutamate receptors, chloride channels capable of filtering glutamate, as well as Potassium (K

objectivesThe current study was undertaken to understand the signal patterns of Cβ-CH MATERIALS AND

methodsNMR spectra of GlyGlu were measured in D

resultsThe sidechain of Glu in the dipeptide dissimilates the β form. The amino group of Gly (Glycine) is protonated and exhibits hydrogen bonding with the main chain carboxylate group of a symmetry-related Glu that is deprotonated in the crystal packing of GlyGlu. The deprotonated main chain carboxylate of Glu is also in hydrogen-bonding distance from the side chain carboxylic acid group that is in the protonated form of a symmetry-related Glu of the dipeptide. The Cβ-CH

conclusionThe results reported will be useful for monitoring changes that Glu and/or molecules in connection to Glu may undergo in

Indexed as

AGEAutismBiomarkerDerivatizationDiabetesDipeptideStructure

Identifiers

PMID34660846
PMCPMC8515908
OpenAlexW3202539809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.